REPROS THERAPEUTICS INC.: cashflow_financing

Value{"amount": 33750000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2012-01-01 – 2012-12-31
Statuscurrent
EntityREPROS THERAPEUTICS INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001144204-13-015663 · Open the official SEC filing →
Retrieved: 2026-08-19T09:01:54.332042+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000897075/cashflow-financing/2012-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/dc68be00-29d7-42cc-8f0d-e5cacd2c9748

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies